Progress in dual-responsive nanocarriers based on acid sensitivity for anticancer drug
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China (Nos. 21476172, 21506161, 21646010), Open Funds from the Key Laboratory of Biomedical Materials in Tianjin (No. 1634-1).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In order to achieve better tumor treatment, researchers have designed dual and multiple responsive smart nanocarriers in the tumor microenvironment. Among them, the research based on acid-sensitive dual-responsive nanocarriers is the most extensive and common one. Intelligent nanocarriers have initially achieved long circulation in body, effective accumulation in tumor cells, and controlled drug release in tumor microenvironment, with increased anti-tumor effect of drug and reduced damage to normal tissues. However, there are still many problems to be solved in current research, such as high price, complicated nanocarriers structure, and unclear mechanisms of drug delivery in the body, all hampering nanocarriers from clinical applications. This article introduces the progress of nanocarriers in recent years from the dual responsive aspects including acid-temperature, acid-magnetism, acid-redox, acid-enzyme, acid-light and acid-ultrasound, to provide reference for further clinical application of nanomedicine.

    Reference
    Related
    Cited by
Get Citation

禄秀娟,郭鑫昊,万冬,潘杰. 基于酸敏感的双响应抗癌药物载体的研究进展[J]. Chinese Journal of Biotechnology, 2020, 36(9): 1723-1731

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:December 25,2019
  • Revised:
  • Adopted:
  • Online: September 25,2020
  • Published:
Article QR Code